Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Tacrolimus vs mycophenolate mofetil to maintain remission

Primary outcome: partial clinical response · idiopathic steroid‐resistant nephrotic syndrome in children

Tacrolimus showed no clear difference in number with partial response at one year compared with mycophenolate mofetil to maintain remission (low certainty).

1 finding from 1 review

Interventions for idiopathic steroid‐resistant nephrotic syndrome in children 2019 · Cochrane Headline outcomes only
RR 4.68 [0.58, 37.68]
1 study · 60 participants
Low

Tacrolimus vs mycophenolate mofetil to maintain remission

Complete or partial remission · idiopathic steroid‐resistant nephrotic syndrome in children

Tacrolimus may leads to higher number with complete or partial response at one year compared with mycophenolate mofetil to maintain remission (low certainty).

1 finding from 1 review

Interventions for idiopathic steroid‐resistant nephrotic syndrome in children 2019 · Cochrane Headline outcomes only
RR 2.01 [1.32, 3.07]
1 study · 60 participants
Low